Related Experiment Video
Updated: Jun 15, 2025

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
Endothelial CLEC5A drives barrier dysfunction and vascular leakage responsible for lung injury in bacterial pneumonia
Tie-Ning Zhang1, Xin-Mei Huang2, Julie E Goodwin3,4,5
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Abstract:
Endothelial barrier dysfunction and the resulting vascular injury are responsible for multiorgan failure in sepsis. Myeloid C-type lectin domain family 5 member A (CLEC5A) is a pattern recognition receptor involved in host defense against infection. Mice lacking CLEC5A were resistant to cecal ligation and puncture (CLP)-induced polymicrobial sepsis and lipopolysaccharide (LPS)-induced endotoxemia, as observed by decreased mortality. Single-cell RNA sequencing revealed transcriptomic heterogeneity of vascular endothelial cells in CLEC5A-deficient lungs following CLP. Endothelial-specific knockdown of CLEC5A improved survival of CLP-challenged mice, which was completely ineffective with reexpression of endothelial CLEC5A. The survival benefits were attributed to alleviated inflammatory storm and vascular leakage. Furthermore, endothelial CLEC5A deficiency protected mice against Escherichia coli-induced pneumonia. In vitro, CLEC5A deletion maintained trans-endothelial electrical resistance, and inhibited adhesion and trans-endothelial migration of monocytes/neutrophils under LPS stimulation. The study unveils the importance of CLEC5A in regulating endothelial barrier function and suggests endothelial CLEC5A as a therapeutic target for pneumonia or sepsis-causing bacterial infection.
Insights
Mice lacking myeloid C-type lectin domain family 5 member A (CLEC5A) showed increased survival in sepsis models. Targeting endothelial CLEC5A may offer a new therapeutic strategy for bacterial infections like pneumonia and sepsis.
Area of Science:
- Immunology
- Vascular Biology
- Microbiology
Background:
- Endothelial barrier dysfunction contributes to multiorgan failure in sepsis.
- Myeloid C-type lectin domain family 5 member A (CLEC5A) is a pattern recognition receptor involved in host defense.
- CLEC5A's role in endothelial barrier integrity during infection is not fully understood.
Purpose of the Study:
- To investigate the role of CLEC5A in endothelial barrier function during sepsis and bacterial pneumonia.
- To determine if targeting endothelial CLEC5A could be a therapeutic strategy.
Main Methods:
- Cecal ligation and puncture (CLP) and lipopolysaccharide (LPS) models of sepsis in mice.
- Endothelial-specific CLEC5A knockdown and reexpression.
- Single-cell RNA sequencing of lung vasculature.
- In vitro assays measuring trans-endothelial electrical resistance and immune cell migration.
Main Results:
- Mice lacking CLEC5A exhibited reduced mortality in CLP-induced sepsis and LPS-induced endotoxemia.
- Endothelial-specific CLEC5A deficiency improved survival and alleviated inflammatory storm and vascular leakage.
- CLEC5A deletion in endothelial cells maintained barrier integrity and reduced immune cell transmigration in vitro.
- Endothelial CLEC5A deficiency protected against *Escherichia coli*-induced pneumonia.
Conclusions:
- Endothelial CLEC5A plays a critical role in regulating endothelial barrier function during sepsis and bacterial pneumonia.
- Targeting endothelial CLEC5A represents a promising therapeutic approach for sepsis and bacterial infections.
More Related Videos
Related Concept Videos
Adherens Junctions
Adherens Junctions are Dynamic
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

